The focus of cancer therapy is moving towards personalized medicine. However, very few efficacious therapies are available for sarcomas. There is a clear unmet need to find new therapies for the broad and heterogeneous group of sarcomas. We are committed to delivering innovative, therapeutic options for the patients who currently have no specific therapies and for those who have exhausted all currently available options.
Sartar exploits principles of precision medicine, drug repurposing and reformulation to provide efficacious cancer therapies faster to the global markets.